Study
Moderate Coffee and Tea Consumption May Lower Dementia Risk in Adults
Drinking 2-3 cups of caffeinated coffee or 1-2 cups of tea daily is linked to a lower risk of dementia.
Summary
In plain language
Recent research suggests that enjoying a moderate amount of caffeinated coffee and tea could help reduce the risk of dementia. The study followed over 130,000 participants for up to 43 years, showing that those who drank 2-3 cups of caffeinated coffee or 1-2 cups of tea daily had a lower chance of developing dementia. While both women and men were included, the benefits were most apparent with regular, moderate intake. The study highlights the potential brain health benefits of these popular beverages, though it's important to remember that not all coffee is the same; decaffeinated options didn't show the same effects. Seniors might consider discussing their coffee and tea habits with their healthcare provider.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study followed a large group of individuals over several decades to see how coffee and tea consumption affected their risk of dementia.
Researchers used data from two long-term studies, focusing on the effects of caffeinated beverages on brain health.
They found that moderate consumption of caffeinated coffee and tea was associated with a lower risk of dementia, with the most benefits seen at 2-3 cups of coffee or 1-2 cups of tea per day.
However, decaffeinated coffee did not show similar benefits, and the study did not prove cause and effect.
Seniors may want to consider these findings when choosing their daily drinks and discuss any changes with their healthcare provider.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Moderate Coffee and Tea Consumption May Lower Dementia Risk in Adults
Published September 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored September 22, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored well on statistical integrity due to robust analysis methods and adjustments for confounders. However, it lacked randomization and blinding, limiting bias control. Transparency was moderate, with adherence to STROBE but no pre-registration. The study's relevance to older adults was limited by the mixed-age cohort. Published in a high-quality journal, it benefits from strong journal reliability.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 6.7/10 | |
| Bias control | 3.3/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 5.0/10 | |
| Conflicts & funding | 7.5/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 5.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
The study investigates the association between coffee and tea intake and dementia risk, finding that higher caffeinated coffee and tea consumption is linked to lower dementia risk and better cognitive function in a large cohort over 43 years.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Dementia
Dementia is a broad term used to describe a decline in cognitive function that interferes with daily life. It predominantly affects older adults, with symptoms like memory loss and changes in behavior. Dementia is not a normal part of aging, and early diagnosis is crucial for management.
Alzheimer's Disease
Alzheimer's disease is a progressive neurological disorder that affects memory, thinking, and behavior. It primarily impacts older adults, with symptoms gradually worsening over time. As the most common cause of dementia, Alzheimer's can lead to a significant decline in daily functioning and independence.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.